ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$35.55
−2.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 150.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.36x
- Price / sales
- —
- Price / cash flow
- -20.43x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- —
- EV / EBITDA
- -14.22x
- EV / EBIT
- 26.06x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026